Atara Biotherapeutics (ATRA) Insider Trading & Ownership $10.68 -0.31 (-2.82%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Atara Biotherapeutics (NASDAQ:ATRA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$204,878.87 Get ATRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Atara Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ATRA Insider Buying and Selling by Quarter Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Atara Biotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/18/2024Anhco NguyenCEOSell1,664$11.20$18,636.80 11/18/2024Eric J HyllengrenCFOSell1,364$11.20$15,276.80 11/18/2024Jill HenrichEVPSell1,000$11.20$11,200.00 8/16/2024Anhco NguyenEVPSell1,821$6.63$12,073.23 8/16/2024Eric J HyllengrenCFOSell1,070$6.63$7,094.10 8/16/2024Pascal TouchonCEOSell3,038$6.63$20,141.94 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/16/2024Anhco NguyenEVPSell1,715$15.50$26,582.50 5/16/2024Eric J HyllengrenCFOSell1,145$15.50$17,747.50 5/16/2024Pascal TouchonCEOSell3,260$15.50$50,530.00 3/4/2024Anhco NguyenEVPSell429$18.00$7,722.00 3/4/2024Pascal TouchonCEOSell993$18.00$17,874.00 (Data available from 1/1/2013 forward) ATRA Insider Trading Activity - Frequently Asked Questions Who is on Atara Biotherapeutics's Insider Roster? The list of insiders at Atara Biotherapeutics includes Amar Murugan, Anhco Nguyen, Carol Giltner Gallagher, Eric J Hyllengren, Jakob Dupont, Jill Henrich, Pascal Touchon, Utpal Koppikar, and William K Heiden. Learn more on insiders at ATRA. What percentage of Atara Biotherapeutics stock is owned by insiders? 3.70% of Atara Biotherapeutics stock is owned by insiders. Learn more on ATRA's insider holdings. Which Atara Biotherapeutics insiders have been buying company stock? The following insiders have purchased ATRA shares in the last 24 months: Carol Giltner Gallagher ($39,380.00), and William K Heiden ($25,000.00). How much insider buying is happening at Atara Biotherapeutics? Insiders have purchased a total of 11,160 ATRA shares in the last 24 months for a total of $64,380.00 bought. Which Atara Biotherapeutics insiders have been selling company stock? The following insiders have sold ATRA shares in the last 24 months: Amar Murugan ($46,603.50), Anhco Nguyen ($68,466.03), Eric J Hyllengren ($74,383.65), Jakob Dupont ($18,331.50), Jill Henrich ($11,200.00), Pascal Touchon ($288,526.19), and Utpal Koppikar ($38,379.00). How much insider selling is happening at Atara Biotherapeutics? Insiders have sold a total of 24,832 Atara Biotherapeutics shares in the last 24 months for a total of $545,889.87 sold. Atara Biotherapeutics Key ExecutivesDr. Anhco Nguyen Ph.D. (Age 51)President, CEO & Director Compensation: $696.34kMr. K. Amar Murugan (Age 48)Executive VP & Chief Legal Officer Compensation: $718.5kMr. Eric Hyllengren (Age 48)Executive VP & Chief Financial Officer 2 recent tradesAlex ChapmanVice President of Corporate Communications & Investor RelationsMs. Jill Henrich (Age 61)Executive VP and Global Head of Regulatory Affairs & Quality 1 recent tradesMr. Dan MaziaszExecutive VP & Chief Business OfficerMs. Rajani Dinavahi M.D.Senior VP & Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies AlloVir Insider Transactions Cortexyme Insider Transactions Trevi Therapeutics Insider Transactions Biomea Fusion Insider Transactions TScan Therapeutics Insider Transactions Sutro Biopharma Insider Transactions MacroGenics Insider Transactions Zentalis Pharmaceuticals Insider Transactions Inhibrx Insider Transactions Zura Bio Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:ATRA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atara Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atara Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
